Finance
Cylex raises $18.4 million in third round of private financing
Published in Obesity and Diabetes Week, January 1st, 2007
The private offering was co-led by Channel Medical Partners and Canaan Partners.
"Our investors have recognized the importance of Cylex being first to market with an FDA-approved cellular immune function assay. Cylex has already had an important impact on the treatment of transplant recipients and is becoming a leader in the worldwide multi-billion dollar immune monitoring market," said Judith A. Britz, PhD, chairman and CEO of Cylex. "We have made important strides in advancing ImmuKnow as a standard of care at prestigious...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Obesity Research
Mindless eating leads us to eat 28-45% more calories when foods are low-fat - Pediatric Obesity
Obesity is cited as the number one kids' health issue - Obesity and Diabetes
New findings from Hospital for Sick Children in the area of obesity and diabetes described - Obesity and Diabetes
New obesity and diabetes research from State University of New York outlined - Obesity and Diabetes
New obesity and diabetes study findings have been published by scientists at Steno Diabetes Center - Obesity and Diabetes
Researchers from Erciyes University provide details of new studies and findings in the area of obesity and diabetes in adolescents - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
